On September 23, scientists revealed that high-fat diets actively suppress the ACC1 enzyme within specific immune cells, offering a cellular explanation for obesity-driven adipose tissue inflammation. According to a recent metabolic study, this suppression disrupts the delicate balance of energy supply and lipid metabolism, driving the chronic inflammation associated with metabolic diseases.
Disrupting the Cellular Balance
Adipose tissue relies on ILC2 immune cells to maintain metabolic health and an anti-inflammatory environment. These cells depend on the ACC1 enzyme to regulate lipid metabolism. However, when the surrounding environment is flooded with fatty acids from energy-dense foods, the cellular production of this enzyme halts. While this inhibition naturally prevents excess fat creation within the cell, it simultaneously cripples the maintenance and overall function of ILC2 cells.
A Self-Reinforcing Cycle of Inflammation
The research team, led by Prof. Christoph Wilhelm, observed that this metabolic impairment creates a destructive loop. The suppression of ACC1 interferes with mitochondrial energy production inside the immune cells. As a result, the adipose tissue becomes enlarged and inflamed, which heavily predisposes the subjects to diabetes. Co-first authors Fotios Karagiannis and Maria Rafailia Theodorou noted that this elevated fatty acid uptake fundamentally breaks the self-regulating capacity of the tissue.
These findings highlight that treatments targeting metabolic conditions cannot solely focus on fat reduction without considering immune function. Because the underlying causes of this chronic inflammation are deeply tied to immune cell metabolism, future therapeutic approaches must account for these cellular dynamics to effectively combat obesity-related diseases.